Publications Office of the EU
Léčivé přípravky s obsahem cyklofosfamidu, ifosfamidu, dekarbazinu a carmustinu - EU tenders
DisplayCustomHeader
MyPortal
Language Selector
English
BasketSummary
Procurement Detail Actions Portlet

Utilities

Procurement Detail Actions Portlet
OP Portal - Procurement - Details

Léčivé přípravky s obsahem cyklofosfamidu, ifosfamidu, dekarbazinu a carmustinu

Overview
  • Published
    18/02/2025
  • Today
    18/03/2025
  • Deadline
    21/03/2025
Status
Published
Type of contract
Supplies
Subject for Renewal
No
Buyer
Fakultní nemocnice Hradec Králové
Place of performance
NUTS code: Multiple place of performance
Location of buyer
NUTS code: CZ052 Královéhradecký kraj
Business sector (Main CPV)
33652100 Antineoplastic agents
Total estimated contract value (excluding VAT)
9,583,000.00 CZK
Total final contract value (excluding VAT)
Not available
Number of lots
4
Procedure details
Tender reference number
29/2025
Description

Předmětem veřejné zakázky jsou průběžné dodávky léčivých přípravků s obsahem cyklofosfamidu, ifosfamidu, dekarbazinu a carmustinu po dobu 4 let dle aktuálních potřeb zadavatele .

Submission Method
Electronic via:
https://www.egordion.cz/nabidkaGORDION/profilFNHK
Tenders may be submitted
Electronic submission: required
https://www.egordion.cz/nabidkaGORDION/profilFNHK
Information about a public contract, a framework agreement or a dynamic purchasing system (DPS)
Not available
Conditions for opening tenders (date)
Not available
Place of performance
CZ052 Královéhradecký kraj
CZ Česko
CPV code

33652100 - Antineoplastic agents

Lots (4)
Documents
Prior information
Contract
Award
Footnote - legal notice

This content published on this page is meant purely as an additional service and has no legal effect. The Union's institutions do not assume any liability for its contents. The official versions of the relevant tendering notices are those published in the Supplement of Official Journal of the European Union and available in TED. Those official texts are directly accessible through the links embedded in this page. For more information please see Public Procurement Explainability and Liability notice.